Award
Delivery Order #SPE2DR26FQZ2L
Delivery Order for Dupixent under Pharmaceutical Supply Contract
Buyer
Defense Logistics Agency
Award Amount
$128,691.72
Ceiling
$128,691.72
Awarded
March 16, 2026
Period of Performance
Mar 16, 2026 – Mar 17, 2026
Identifier
SPE2DR26FQZ2L
NAICS
424210
This award represents a delivery order contract issued under a larger indefinite delivery vehicle (IDV) pharmaceutical supply agreement previously awarded to AmerisourceBergen Drug Corporation, a prominent pharmaceutical services and distribution company. The contract covers the procurement of a specific pharmaceutical product, Dupixent 300 mg/2 ml pen, a medication essential for treating certain health conditions. This procurement supports the agency's effort to maintain consistent access to critical medications, directly impacting public health initiatives. The scope involves the delivery of this pharmaceutical product at the designated performance location, ensuring timely availability. The order was issued as part of an established contract framework, indicating a non-competitive, task-order based procurement process under the original IDV. Key milestones include the order's execution and completion within a brief, specified timeframe in March 2026. This delivery order contributes to the ongoing fulfillment of the broader pharmaceutical supply requirements under the existing contract umbrella.
Description
4571157567!DUPIXENT 300 MG/2 ML PEN 2ML